Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection.
Michael Grimley, Gabriela M. Marón, Carlos A Gomez, Vinod K Prasad, Jasmeen Dara, Thomas Lion, Genovefa A Papanicolaou, Koji Fukushima, Robert F Wynn, Michael J. Boeckh
